Generate a tailored SOP for Dr. Hagar Labouta. Improve your application with a focused, well-structured draft.
Hagar Labouta is an Assistant Professor at the Leslie Dan Faculty of Pharmacy, University of Toronto. She leads a multidisciplinary research program that focuses on the intersection of nanoscience, microfluidics, and organ-on-a-chip technology. Her research is centered on designing and evaluating novel nanoparticles for drug delivery, with a specific emphasis on their interactions with biological barriers. The primary goal of her work is to bridge the gap between fundamental research and clinical applications, translating her findings into the development of safe and efficacious therapies. Dr. Labouta's team also addresses significant challenges in the field such as predicting nanoparticle behavior within complex biological environments, and developing comprehensive models for nanoparticle interactions. Notably, she has made significant contributions to materials science and engineering, leading to the development of various nanoparticles for pharmaceutical applications and holds an international patent for nanosystems targeting. Her work in organ-on-a-chip models has shown the effects of flow-induced changes on cell physiology, influencing the design of nanoparticle therapies. Dr. Labouta's research continues to explore innovative solutions for prenatal nanomedicine, targeting maternal-fetal health and addressing unmet medical needs in prenatal care.
University of Toronto • Toronto, Canada
Teaching and conducting research in the field of pharmacy with a focus on nanomedicine and drug delivery systems.
Department of Sociology